FDA grants de novo authorization to AI-powered Scanly Home OCT device

The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.

Related Keywords

Kester Nahen ,Davida Eichenbaum , ,Scanly Home ,Notal Vision ,Medicare Administrative Contractors ,